By Josh White
Date: Tuesday 03 Jun 2025
(Sharecast News) - Renalytix announced a new collaboration with New York Kidney & Hypertension Medicine (NYKHM) on Tuesday, aimed at expanding access to its FDA-approved kidneyintelX.dkd test across underserved communities in the Greater New York area.
By Iain Gilbert
Date: Thursday 10 Apr 2025
(Sharecast News) - Precision medicine business Renalytix said on Thursday that Q3 trading was in line with expectations, delivering 20% quarter-on-quarter revenue growth as it reached "the key milestone" of processing over 1,000 billable tests within the quarter for the first time.
By Josh White
Date: Tuesday 20 Aug 2024
(Sharecast News) - Renalytix, a company specialising in artificial intelligence-enabled diagnostics for kidney disease, announced the termination of its formal sale process on Tuesday.
Currency | UK Pounds |
Share Price | 7.16p |
Change Today | -0.095p |
% Change | -1.31 % |
52 Week High | 19.25p |
52 Week Low | 6.75p |
Volume | 54,038 |
Shares Issued | 189.93m |
Market Cap | £13.59m |
Beta | 0.01 |
RiskGrade | 348 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
08:20 | 54,038 @ 7.38p |
You are here: research